Skip to main content
logo
Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
23.80
-0.40 (-1.65%)
Aug 24, 2026, 12:40 PM IDT

TLV:CBI Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3848556298185
Market Cap Growth
-21.94%-12.89%-12.09%-36.78%-46.87%-41.79%
Enterprise Value
557491109144336
Last Close Price
0.240.300.350.400.631.18

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-321.67--598.73266.21827.64
PB Ratio
2.522.081.190.510.680.55
P/TBV Ratio
2.972.361.490.630.78-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---1046.55389.641498.60
EV/EBITDA Ratio
----28.0634.03

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.080.780.450.300.250.16
Debt / EBITDA Ratio
----7.155.45
Net Debt / Equity Ratio
0.970.700.340.190.170.00
Net Debt / EBITDA Ratio
-3.72-3.56-2.49-2.324.640.07
Net Debt / FCF Ratio
-4.45-4.07-2.44-2.63-0.39-0.02
Asset Turnover
---0.000.000
Quick Ratio
0.200.100.252.014.651.70
Current Ratio
0.200.140.292.215.712.18
Return on Equity (ROE)
-64.25%-58.43%-89.60%-21.10%-16.98%-15.63%
Return on Assets (ROA)
-6.05%-5.39%-3.67%-3.73%-2.49%-1.49%
Return on Capital Employed (ROCE)
-26.40%-19.50%-13.90%-6.70%-7.00%-3.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-23.34%-27.93%-114.10%-49.87%-62.68%-48.32%
FCF Yield
-8.67%-8.28%-11.83%-13.68%-61.23%-23.15%
Buyback Yield / Dilution
-3.38%---1.01%1.74%
Total Shareholder Return
-3.38%---1.01%1.74%